John M. Gregory (American pharmaceuticals executive)

From Wikipedia, the free encyclopedia

For other persons named John Gregory, see John Gregory (disambiguation).

John M. Gregory is a former CEO of King Pharmaceuticals and resides in Bristol. In addition to having strated up King Pharma back in 1994, Gregory has started up several other notable business ventures including SJ Strategic Investments (a privately held investment firm) and Leitner Pharmaceuticals. Most recently, Gregory has also made major investment outside of the pharmaceutical industry, such as his investment within the privately held United Coal Company located in southwest Virginia.

Contents

[edit] King Pharma acquiring U.S. rights to Altace

During 1994, the U.S. National Right to Life Committee announced an anti-RU-486 boycott, tageting all Hoechst pharmaceutical products including Altace. By September 17, the pro-life organization, Pharmacists For Life International, joined the NRLC anti-RU-486 boycott "...against the American subsidiary of Hoechst, AG Hoechst-Roussel, Hoechst-Celanese, its generic subsidiary Coply Pharmaceuticals and the agricultural Hoechst subsidiary"[1] while asking U.S. consumers to "...focus on key Hoechst drugs which have the most economic impact rather than taking an across-the-board shotgun approach"[1] and specifically targeting Altace as a boycott list item.[1][2]

Hoechst merged with Marion Merrill Dow of Kansas City, Missouri in 1995, forming the Hoechst U.S. pharmaceutical subsidiary Hoechst Marion Roussel (HMR). Altace was bringing in under $90 million in U.S. revenues for HMR and Hoechst had stopped promoting Altace within the United States.[3], and King Pharmaceuticals President Jefferson "Jeff" Gregory also began negotiations in 1995 with Hoechst to acquire U.S. distribution rights to Altace.[3]

The King Pharmaceuticals wholly owned subsidiary Monarch Pharmaceuticals, Inc. (another brother - Joseph Gregory - was then the president of Monarch Pharmaceuticals) acquired ownership of the U.S. distribution and marketing rights to Altace and other Hoescht products from Hoescht AG subsidiary Hoechst Marion Roussel of Kansas City, Missouri on December 18, 1998, and [4] following a January 1999 merger with Rhône-Poulenc, Hoechst assummed the new corporate identity of Aventis).

In 2001, Forbes magazine ranked Gregory among the 400 richest Americans. The bulk of Gregory's personal fortune was due in large part due to the ability of King Pharma to reintroduce the prescription drug Altace back into the U.S. market under the King Pharma subsidiary Monarch Pharmaceuticals brand following the 1998 U.S. marketing and distribution agreement between King and Hoechst/HMR.

[edit] Political connection to Altace, pharmaceutical industry

Gregory, along with his family members and subordinate company executives, has been making considerable financial impact through his political campaign donations to Republican candidates in Tennessee, Viriginia and Maryland state elections and within both U.S. congressional and presidential elections on the federal level, with extremely large amounts of his money being donated to the treasury of his very own Tennessee Conservative PAC which he created and other political action committees supporting Republican candidates. Gregory is also a prominent campaign contributor to pro-life political action committees in Tennessee:

  • the Tennessee Right To Life PAC[5]
  • the State of Franklin PAC[6], and ;
  • the Tennessee Conservative PAC.[7]

Gregory financed and founded the Tennessee Conservative PAC as the political action committee's original president[8].

Tennessee State Senator Ron Ramsey organized an August 1999 lobbying airlift from Northeast Tennessee aboard King Pharmaceuticals-owned corporate aircraft and flew to a Nashville meeting with TennCare Director Brian Lapps that was also attended by State Representatives Jason Mumpower, Steve Godsey, and David Davis at the request of King Pharmaceuticals lobbyist[9] and former Tennessee State Senator James "Jim" L. Holcomb. The meeting was successful in placing the recently acquired Monarch Pharmaceuticals (a King Pharmaceuticals subsidiary) branded drug Altace onto the TennCare Preferred Drug List within only 33 days.[9] Lapps resigned as TennCare Director on September 27, 1999.[10]

Aventis went on in 1994 to merge with Sanofi-Synthélabo, forming Sanofi-Aventis as the third largest pharmaceutical company in the world.

[edit] See also

[edit] References

  1. ^ a b c "3) Pharmacists For Life Joins International Boycott". Life Communications. November, 1994.
  2. ^ "Abortion Foes To Boycott Drugs (Altace) Made By RU-486 Manufacturer". The Virginia-Pilot. Associated Press. July 8, 1994.
  3. ^ a b "Faith Healers: The born-again Gregory brothers worked a financial miracle from cast-off drug brands". Forbes. Zina Moukheiber. October 28, 2002.
  4. ^ "Monarch Pharmaceuticals acquired". sanofi-aventis Group. December 18, 1998.
  5. ^ "John Gregory uses checkbook to promote conservative causes". Hank Haynes. September 3, 2006.
  6. ^ "Campaign Finance Reform Bill Fails". Andy Spears. May 3, 2005.
  7. ^ "Tennessee Conservative PAC - About Us". Brett Holcomb.
  8. ^ "John M. Gregory: Founder and Chairman". Brett Holcomb.
  9. ^ a b "Leading Democrats castigate King Pharmaceuticals". go4truth.org AP news article. September 30, 2004
  10. ^ " TennCare chief Lapps resigns". Tennessean. Bonna M. de la Cruz. September 28, 1999.

[edit] External links